AC Immune’s Phase II trial showed an increase in anti-a-syn antibodies following treatment with the Parkinson’s disease ...

A multitude of genes have been linked to the development of Alzheimer's disease. Specifically how those genes might influence the progression of neurodegeneration remains something of a black box ...

A team of Tel Aviv University researchers claims to have made progress in the path to treating Parkinson’s disease. The team found that a variant of a protein, caused by a genetic mutation, enhances ...

Researchers are using functionalized nanodiamonds to precisely monitor neuronal activity at the cellular level, enhancing ...

With rising demand and an ageing population, European healthcare systems are under strain. In the second article in our ...

Researchers at Washington University School of Medicine in St. Louis have linked disease-related proteins and genes to identify specific cellular pathways responsible for Alzheimer’s genesis and ...

The 78-year-old broadcaster lifted the lid on how he has been coping with the health news, as well as sharing his opinion on ...

Israeli scientists have identified a promising new factor in the pathology of Parkinson’s disease that could pave the way for ...

A team of researchers from the University of Barcelona and the Bellvitge Biomedical Research Institute (IDIBELL) has identified a potential biomarker of Parkinson's disease progression.

A team of researchers from the University of Barcelona and the Bellvitge Biomedical Research Institute (IDIBELL) has ...

Analysis suggests that the research and development of DMTs and non-motor therapies will diversify Parkinson's treatment ...

Funds raised aid in the battle against Parkinson's Disease and the related ALS (Amyotrophic Lateral Sclerosis) and PSP ...